<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

SmartTRAK Life Sciences News and Analysis Blog

3 min read

SmartTRAK's Q418/FY18 OrthoBio Market Recap

4/8/19, 2:00 PM

OrthoBio Q418-1Advanced, higher priced biologics push the US OrthoBio Market higher

Based on Q418/FY18 SmartTRAK Financial Dashboard reporting:
  • US Bone Replacement grew +2.3% YoY, with FY18 revenues up +2.7%.
  • US Cartilage Replacement increased 55.7% YoY, with FY18 revenues up 34.7%.
  • US Soft Tissue Augmentation grew 2.3%, with FY18 revenues growing 9.2%.
  • US Tendon Allografts posted an 8.4% YoY increase, with FY18 revenues up +3.9% YoY
  • US Meniscal Implant market, with robust growth, was up 15.6% YoY for Q418 with FY18 revenues increasing by 3.0%.

Among the many topics covered in the Q418/FY18 OrthoBio Market Recap are:

  • OrthoBio Market Overview
  • Slower Growth for US Bone Replacement Market
  • Impressive Growth for US Cartilage Replacement
  • Solid Performance for US Soft Tissue Replacement
  • Unprecedented Q418 for US Meniscal Implant Market
  • Q418 Regulatory Highlights
Companies experiencing positive results have been very strategically focused. Start-up and mid-size companies have concentrated on positioning themselves as an expert partner in specific applications. Larger companies continue to refine their portfolios via SKU optimization, expand footprint with new product introductions or applications and improve market position through M&A. These companies are reporting incremental pull through revenue from synergistic sales strategies and improved margins.

According to SmartTRAK Financial Dashboard 2018 year end results, Medtronic remained the overall US market leader, followed by DePuy SynthesZimmer Biomet and Stryker...

Read the entire Q418/FY18 OrthoBio Market Recap including news, data, company revenues and analysis*...

*This article can only be viewed by SmartTRAK subscribers to this module. For information on how to subscribe, please click the button below.

Request SmartTRAK Subscription Info

 

Topics: Orthopedics

Kim French
Written by Kim French

20+ years of progressive medical device and biologics marketing and sales experience in orthopedic biological implants, cellular technologies and biopharmaceuticals. Most recent experience includes President, Trilogy Consulting and Marketing and Sales Management roles at AlloSource and Terumo BCT.

    Recent Articles